These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 24487006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?
    Devranoğlu B, Özdamar Ö, Köle E, Eken MK, Bozdağ H, Doğer E.
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():141-5. PubMed ID: 26930042
    [Abstract] [Full Text] [Related]

  • 3. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L, Noriega-Hoces L, Delgado A, Rubio J, Gonzales-Castañeda C, Gonzales GF.
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [Abstract] [Full Text] [Related]

  • 4. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K, Chaudhury S, Khastgir G, Purakaystha S.
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [Abstract] [Full Text] [Related]

  • 5. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL, Acevedo-Martín B, Chávez M, Manzanares M, Ricciarelli E, Hernández ER.
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [Abstract] [Full Text] [Related]

  • 6. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N, Sylvestre C, Tulandi T, Buckett W.
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [Abstract] [Full Text] [Related]

  • 7. The importance of infertility duration and follicle size according to pregnancy success in women undergoing ovulation induction with gonadotropins and intrauterine insemination.
    Kuru Pekcan M, Tokmak A, Ulubasoglu H, Kement M, Özakşit G.
    J Obstet Gynaecol; 2023 Dec; 43(1):2173058. PubMed ID: 36920100
    [Abstract] [Full Text] [Related]

  • 8. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
    Rashidi M, Aaleyasin A, Aghahosseini M, Loloi S, Kokab A, Najmi Z.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
    [Abstract] [Full Text] [Related]

  • 9. Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism.
    Huseyin K, Berk B, Tolga K, Eser O, Ali G, Murat A.
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):833-838. PubMed ID: 30930300
    [Abstract] [Full Text] [Related]

  • 10. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I, Guillén A, Pacheco A, Requena A, Garcia-Velasco JA.
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [Abstract] [Full Text] [Related]

  • 11. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH, Weghofer A, Gleicher N.
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [Abstract] [Full Text] [Related]

  • 12. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
    Wu HH, Wang NM, Cheng ML, Hsieh JN.
    Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
    [Abstract] [Full Text] [Related]

  • 13. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
    Kocak M, Dilbaz B, Demir B, Taşci Y, Tarcan A, Dede S, Haberal A.
    Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature.
    Merviel P, Heraud MH, Grenier N, Lourdel E, Sanguinet P, Copin H.
    Fertil Steril; 2010 Jan; 93(1):79-88. PubMed ID: 18996517
    [Abstract] [Full Text] [Related]

  • 15. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.
    Erdem M, Abay S, Erdem A, Firat Mutlu M, Nas E, Mutlu I, Oktem M.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld.
    Erman Akar M, Oktay K.
    Arch Gynecol Obstet; 2009 Nov; 280(5):761-5. PubMed ID: 19255769
    [Abstract] [Full Text] [Related]

  • 19. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 20. Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.
    Mitwally MF, Abdel-Razeq S, Casper RF.
    Reprod Biol Endocrinol; 2004 Jul 07; 2():55. PubMed ID: 15239837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.